triazolam has been researched along with Airway Obstruction in 1 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
Airway Obstruction: Any hindrance to the passage of air into and out of the lungs.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berry, RB | 1 |
| McCasland, CR | 1 |
| Light, RW | 1 |
1 trial available for triazolam and Airway Obstruction
| Article | Year |
|---|---|
The effect of triazolam on the arousal response to airway occlusion during sleep in normal subjects.
Topics: Adult; Airway Obstruction; Airway Resistance; Arousal; Humans; Male; Polysomnography; Respiration; S | 1992 |